[1]
2025. Eribulin in Heavily Pre-Treated Metastatic Breast Cancer: A Case Series. International Journal of Integrated Health Sciences. 13, 1 (Apr. 2025), 69–76. DOI:https://doi.org/10.15850/ijihs.v13n1.3908.